inebilizumab | Friends of Cancer Research

You are here

inebilizumab

Sponsor: 
Viela Bio
Indication: 
Patients with neuromyelitis optica spectrum disorder (NMOSD)
Year: 
2019
Date: 
Apr 18th
FDA Status: 
Designation Granted